Negative regulation of nuclear factor-κB activation and function by glucocorticoids

Journal of Molecular Endocrinology

Volumn 28, Issue 2, 2002, Pages 69-78

  Almawi, W Y ^a   Melemedjian, O K ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOKINE; CYTOSOL RECEPTOR; DNA; GLUCOCORTICOID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P300; RETINOIC ACID RECEPTOR; STEROID; THYROID HORMONE; TRANSCRIPTION FACTOR; VITAMIN D;

ANTIINFLAMMATORY ACTIVITY; CELL MEMBRANE TRANSPORT; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DRUG ACTIVATION; DRUG CONFORMATION; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; GENETIC TRANSCRIPTION; MOLECULAR MODEL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; TATA BOX; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING, COMPETITIVE; CELL DIVISION; GLUCOCORTICOIDS; HUMANS; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 0036236473     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0280069     Document Type: Review

References (77)

1. CREB-binding protein in androgen receptor-mediated signaling
2. Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells
3. Negative regulation by glucocorticoids through intereference with a cAMP responsive enhancer
4. Post-transcriptional mechanisms of glucocorticoid anti-proliferative effects. Glucocorticoids inhibit IL-6-induced proliferation of B9 hybridoma cells
5. Mode of action of the glucocorticosteroids as immunosuppressive agents
6. Abrogation of glucocorticosteroid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma
7. Regulation of Cytokine and cytokine receptor expression by glucocorticoids
8. Partial mediation of glucocorticoid anti-proliferative effect by lipocortins
9. Multiplicity of glucocorticoids action in inhibiting allograft rejection
10. Significance of enhanced cytokine receptor expression by glucocorticoids
11. Transcriptional and posttranscriptional mechanisms of glucocorticoid antiproliferative effects
12. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation
13. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
14. NF-κB: Ten years after
15. The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors
16. Therapeutic benefit of dissociated glucocorticoids and the relevance of in vitro separation of transrepression from transactivation activity
17. DNA binding specificity of steroid receptors
18. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats
19. Glucocorticoids therapy for immune-mediated diseases: Basic and clinical correlates
20. Anti-inflammatory effects of glucocorticoids in brain cells, independent of NF-κB
21. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the anti-inflammatory action of glucocorticoids
22. Inhibition of NF-AT-dependent transcription by NF-κB: Implications for differential gene expression in T helper cell subsets
23. Glucocorticoids inhibit calcium-and calcineurin-dependent activation of the human IL-4 promoter
24. Identification of calcineurin as a key signaling enzyme in T lymphocyte activation
25. IKAP is a scaffold protein of the IκB kinase complex
26. Transrepression of NF-κB is not required for glucocorticoid protection of TNF-α-induced apoptosis on fibroblasts
27. Selective inhibition of NF-κB activation and TNF-α production in macrophages by red blood cell-mediated delivery of dexamethasone
28. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells
29. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation
30. Mechanisms of anti-inflammatory action and of immuno-suppression by glucocorticoids: Negative interference of activated glucocorticoid receptor with transcription factors
31. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell
32. The steroid and thyroid hormone receptor superfamily
33. Increasing the complexity of coactivation in nuclear receptor signaling
34. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
35. NF-κB and Rel proteins: Evolutionary conserved mediators of immune responses
36. Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution
37. Induction of cyclooxygenase-2 by platelet-derived growth factor (PDGF) and its inhibition by dexamethasone are independent of NF-κB/IκB transcription factors
38. Transcriptional cross-talk, the second mode of steroid hormone receptor action
39. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor κB in asthma
40. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1α
41. IκBα-independent downregulation of NF-κB activity by glucocorticoid receptor
42. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
43. Conditional modulation of glucocorticoids receptor activities by CREB-binding protein (CBP) and p300
44. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB
45. Transcriptional regulation of steroid receptor coactivator-1 (SRC-1) in glucocorticoids action
46. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells
47. Opening a window on thymic positive selection: Developmental changes in the influence of cosignaling by integrins and CD28 on selection events induced by TCR engagement
48. The interleukin-1 type 2 receptor gene displays immediate gene responsiveness in glucocorticoid-stimulated human epidermal keratinocytes
49. CBP (CREB binding protein) integrates NF-κB (nuclear factor-κB) and glucocorticoids receptor physical interactions and antagonism
50. The three dimensional structure of peptide-MHC complexes
51. Molecular genetics of corticosteroid action
52. Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone
53. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2
54. Co-localization of elements required for phorbol ester stimulation and glucocorticoid repression of proliferin gene expression
55. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids
56. Novel mechanism of glucocorticoids-mediated gene repression. Nuclear factor-κB is target for glucocorticoids-mediated interleukin 8 gene repression
57. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor-κB-mediated transactivations
58. Effect of dexamethasone on interleukin-1β-(IL-1β)-induced nuclear factor-κB (NF-κB) and κB-dependent transcription in epithelial cells
59. The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the mRNA polymerase II carboxy-terminal domain
60. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor
61. The dominant negative activity of the human glucocorticoid receptor β isoform. Specificity and mechanisms of action
62. Glucocorticoids regulate calcineurin-dependent trans-activating pathways for interleukin-2 gene transcription in human T lymphocytes
63. Negative regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT
64. Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites
65. Induction of IκBα mRNA expression in the brain by glucocorticoids: A negative feedback mechanism for immune-to-brain signaling
66. Cytokines and their receptors: Molecular mechanism of interleukin-6 gene repression by glucocorticoids
67. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoids receptor
68. Glucocorticoids inhibit proliferation and adhesion of the IL-3-dependent mast cell line, MC/9, to NIH/3T3 fibroblasts, with an accompanying decrease in IL-3 receptor expression
69. p57 Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells
70. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids
71. Nuclear integration of glucocorticoids receptor and nuclear factor-κB signaling by CREB-binding protein and steroid receptor coactivator-1
72. Antigen-specific regulation of T cell-mediated cytokine production
73. Glucocorticoids suppress tumor necrosis factor-α expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-κB and c-Jun-activating transcription factor-2 binding sites in the promoter
74. 2000 Cell specific effects of glucocorticoid treatment on the NF-κB p65/IκB system in patients with Crohn's disease
75. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements
76. Complex complexes: Signaling at the TCR
77. STAT3 acts as a coactivator of glucocorticoid receptor signaling